Get AI match insights
See your fit score & personalized tips.
Happiness score
40/100
Based on 30 verified employee signals
Stripe reports 41% first-half revenue growth
Stripe told investors that first-half 2026 revenue rose 41% year over year and free cash flow increased 43%, according to an investor letter obtained by Axios.
Stripe appoints Eileen O'Mara vice chair and Tyler Bryson CRO
Stripe named former chief revenue officer Eileen O'Mara vice chair and promoted Tyler Bryson, who joined in 2025 after more than two decades at Microsoft, to chief revenue officer.
Stripe unveils 288 products and features at Sessions 2026
Stripe's launches included Link wallets for AI agents, an expanded Agentic Commerce Suite, stablecoin-backed cards in 30 countries, and broader access to its Managed Payments product.
Employee tender offer values Stripe at $159 billion
Stripe signed a tender offer backed mainly by Thrive Capital, Coatue, Andreessen Horowitz and other investors, providing employee liquidity at a $159 billion valuation.
AI Generated Insights
You will own the end‑to‑end investment pipeline: sourcing candidates, conducting deep scientific diligence, driving grant/equity transactions, and managing portfolio projects to accelerate their development.
The team seeks an experienced biotech or bio‑health investor with strong scientific diligence skills, the ability to synthesize complex science into investment theses, and a track record of independent, action‑oriented work.
This role is critical to building Intercept’s portfolio of air‑cleaning and broad‑spectrum preventative technologies that aim to dramatically reduce the global burden of respiratory viruses.
Ideal candidates are seasoned investors who can translate deep scientific insight into capital deployment decisions, thrive in a small, cross‑functional team, and communicate complex concepts to diverse audiences.
Role verticals
Platforms & tools
Stripe is a financial infrastructure platform for businesses. Millions of companies - from the world’s largest enterprises to the most ambitious startups - use Stripe to accept payments, grow their revenue, and accelerate new business opportunities. Our mission is to increase the GDP of the internet, and we have a staggering amount of work ahead. That means you have an unprecedented opportunity to put the global economy within everyone's reach while doing the most important work of your career.
This role is on the Intercept team, which is part of Stripe's broader collection of public goods initiatives, including Frontier.
Respiratory viruses kill 1 million people a year, cost us $600B annually, disrupt everyday life, and periodically threaten civilization. Recent breakthroughs may make it possible to develop and deploy broad-spectrum preventatives and air cleaning technologies that defend against common respiratory infections. Intercept is a $500M philanthropic initiative that aims to radically reduce the burden of respiratory infections, and eventually eliminate them altogether. Learn more about Intercept via our launch post and our website
Intercept is looking for an experienced biotech/biohealth investor to join our team.
We’re working to make sure the portfolio of technologies needed to radically reduce the burden of respiratory viruses exists. We have two main focus areas: air-cleaning technologies (ACT’s) and broad-spectrum preventatives (BSPs). For BSPs, our goal is to advance 2+ products that meet our target product profile through Phase 2. We make both grants and investments, using the most capital-efficient tool to advance our target product profile.
Initially, this role will be focused on building internal investment processes, investment thesis, and supporting Intercept in establishing the investment function. Ultimately this role will focus on sourcing, diligencing, and executing on pipeline opportunities to make equity and/or grant investments in companies that have the most promising BSPs against our target product profile (TPP). In addition, the role will be responsible for portfolio management to make sure portfolio projects successfully advance their products by helping to remove bottlenecks and accelerate timelines. To effectively accomplish this work, the Investment Lead will develop views on the most promising approaches, identify new cutting edge areas of science, understand key product development inflection points, including mapping key technical and clinical/regulatory bottlenecks and developing plans to de-risk / mitigate them.
We need someone who can go deep on scientific and development diligence while also zooming out to synthesize how findings impact our capital deployment plan and long-term goals. A successful candidate will be action-oriented and comfortable working independently (vs. waiting to be told what to do) and a great communicator who can translate complex science for diverse audiences.
Intercept is a small team; you'll work with the entire team, many partners, and wear many hats. You'll own specific outcomes end-to-end and have a chance to contribute to BSP strategy over time.
Future opportunities for growth
We're looking for someone who meets the minimum requirements to be considered for the role. If you meet these requirements, you are encouraged to apply. The preferred qualifications are a bonus, not a requirement.
Stripe
Full employer profile →
